跳到正文
openFDA 已分级药品召回执法报告·· 12 天前精选AI 评分60

FDA 执法报告 D-0182-2027:Advagen Pharma 酒石酸美托洛尔片因混入外来片剂或胶囊列为 II 类召回

FDA drug enforcement D-0182-2027: Advagen Pharma Limited — Presence of Foreign Tablets/Capsules

AI 导读

FDA 于 2026-11-11 发布的执法报告将 Advagen Pharma Limited 的酒石酸美托洛尔片 USP 50 mg 召回列为 II 类,原因为产品中存在外来片剂或胶囊。

推荐理由

记录列出 II 类召回的批次、数量与分销范围,便于核对同一 event_id 下的其他产品记录。

正文 · 原文

FDA drug recall enforcement report — D-0182-2027

Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "50 Millstone Rd Bldg 200",

"address_2": "",

"center_classification_date": "20261110",

"city": "East Windsor",

"classification": "Class II",

"code_info": "Batch#: 2611C065A1: Expiry: 05/2028",

"country": "United States",

"distribution_pattern": "U.S. Nationwide",

"event_id": "100234",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"ANDA200981"

],

"brand_name": [

"METOPROLOL TARTRATE"

],

"generic_name": [

"METOPROLOL TARTRATE"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"Advagen Pharma Ltd"

],

"package_ndc": [

"72888-208-01",

"72888-208-05",

"72888-208-00",

"72888-208-02",

"72888-209-01",

"72888-209-05",

"72888-210-01",

"72888-210-05",

"72888-210-00",

"72888-210-02",

"72888-211-01",

"72888-211-05",

"72888-212-01",

"72888-212-05",

"72888-212-00"

],

"product_ndc": [

"72888-208",

"72888-209",

"72888-210",

"72888-211",

"72888-212"

],

"product_type": [

"HUMAN PRESCRIPTION DRUG"

],

"route": [

"ORAL"

],

"rxcui": [

"866511",

"866514",

"866924",

"1606347",

"1606349"

],

"spl_id": [

"5ddfcd4c-5388-13b9-e063-6394a90aea69"

],

"spl_set_id": [

"3ecff825-34ea-4535-b935-627bf2c13d93"

],

"substance_name": [

"METOPROLOL TARTRATE"

],

"unii": [

"W5S57Y3A5L"

],

"upc": [

"0372888212005",

"0372888209050",

"0372888208008",

"0372888209012",

"0372888211053",

"0372888212012",

"0372888212050",

"0372888211015",

"0372888210056",

"0372888208015",

"0372888210001",

"0372888210018",

"0372888208053"

]

},

"postal_code": "08520-1415",

"product_description": "Metoprolol Tartrate Tablets, USP, 50 mg, 1,000 Tablets per bottle, Rx Only, Distributed by: Advagen Pharma Ltd., East Windsor, NJ 08520, USA. NDC: 72888-210-00.",

"product_quantity": "3684 bottles",

"product_type": "Drugs",

"reason_for_recall": "Presence of Foreign Tablets/Capsules",

"recall_initiation_date": "20261027",

"recall_number": "D-0182-2027",

"recalling_firm": "Advagen Pharma Limited",

"report_date": "20261111",

"state": "NJ",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov